AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.360
+0.040 (1.72%)
Aug 7, 2026, 4:00 PM EDT - Market closed
AC Immune Cash Flow Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -43.16 | -70.45 | -50.92 | -54.23 | -70.75 | -73 |
Depreciation & Amortization | 2.28 | 2.5 | 2.16 | 2.22 | 2.36 | 2.41 |
Stock-Based Compensation | 4.35 | 4.4 | 5.47 | 4.37 | 3.33 | 4.13 |
Other Adjustments | -2 | -0.65 | 0.18 | 1.99 | 0.34 | -5.59 |
Change in Receivables | -12.06 | 0.92 | 13.55 | -14.87 | 0.6 | 0.5 |
Changes in Accounts Payable | -1.44 | -0.59 | 0.98 | 0.77 | -1.07 | -0.08 |
Changes in Accrued Expenses | -4.19 | -3.86 | 1.37 | 1.14 | -6.11 | 5.21 |
Changes in Unearned Revenue | 2.96 | -3.57 | 89.48 | -0.45 | -0.13 | 0.43 |
Changes in Other Operating Activities | -0.29 | 2.04 | 3.57 | -1.33 | -2.13 | 0.32 |
Operating Cash Flow | -50.49 | -69.26 | 65.84 | -60.41 | -73.57 | -65.69 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.59 | -0.9 | -0.58 | -0.8 | -1.24 | -2.64 |
Sale of Property, Plant & Equipment | - | 0.02 | - | - | - | - |
Purchases of Investments | 53.81 | 64.6 | -104.66 | 66.45 | 25 | -51 |
Other Investing Activities | - | -0.17 | -0.05 | - | 0 | -0.03 |
Investing Cash Flow | 53.22 | 63.54 | -105.29 | 65.65 | 23.76 | -53.66 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | - | - | - | 23.46 |
Net Long-Term Debt Issued (Repaid) | - | - | - | - | - | 23.46 |
Issuance of Common Stock | 0.59 | 0.01 | 0.11 | 43.8 | -0 | 17.8 |
Net Common Stock Issued (Repurchased) | 0.59 | 0.01 | 0.11 | 43.8 | -0 | 17.8 |
Other Financing Activities | -0.96 | -1.03 | -0.71 | -0.55 | -1.35 | 0.26 |
Financing Cash Flow | -0.37 | -1.02 | -1.12 | 43.25 | -1.35 | 40.75 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.32 | -2.74 | -1.65 | -1.58 | 0.52 | -0.07 |
Net Cash Flow | 1.27 | -6.74 | -40.57 | 48.49 | -51.15 | -78.61 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -51.09 | -70.16 | 65.27 | -61.21 | -74.81 | -68.32 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | -291.78% | -1963.67% | 238.99% | -413.55% | -1901.07% | - |
Free Cash Flow Per Share | -0.50 | -0.70 | 0.65 | -0.72 | -0.90 | -0.91 |
Levered Free Cash Flow | -44.42 | -74.83 | 46.07 | -52.69 | -79.08 | -43.89 |
Unlevered Free Cash Flow | -45.78 | -73.89 | 44.32 | -55.06 | -81.87 | -75.73 |